Reliance invests in oncology startup Karkinos Healthcare

Reliance Digital Health has invested an undisclosed amount in the oncology healthcare platform Karkinos Healthcare. Read to know more about its other investors.

Reliance Digital Health has invested an undisclosed amount in the oncology healthcare platform Karkinos Healthcare. ‘Kark’ in Hindi means cancer whereas ‘nos’ means elimination. Its headquarter is in Mumbai but its operations take place in 4 locations in Kerala. 

It was launched in July 2020 and is made up of ex-Tata group members. R Venkataramanan and Ravi Kant are the co-founders of Karkinos. The former was the former managing trustee of Tata Trusts and the latter was the former vice-chairman and MD of Tata Motors.

This may be the prime cause that the startup was personally backed by Ratan Tata and the Tata Group. This year Tata Group invested Rs 110 crore in this platform. Initially, Rs 35 crore will be invested and the rest of the capital will be kept in tranches.

Tatas have been actively seeking ways to enter the healthcare segment. With Tata Medical they entered into Covid testing and diagnostics; with Tata1MG they entered the pharmacy segment and with Tata Health they entered in teleconsultation.

Its other investors are Venu Srinivasan, Ronnie Screwvala, Vijay Shekar Sharma, Kris Gopalakrishnan and Bhavish Aggarwal. The startup is also backed by USA-based Rakuten Medical. The San Diego venture is a global clinical-stage biotechnology firm. Karkinos is also setting up a cancer control centre at Jawaharlal Nehru Institute of Medical Sciences.

Tags : #KarkinosHealthcare #RVenkataramanan #RaviKant #RatanTata #Reliance #RelianceDigitalHealth #TataGroup #VenuSrinivasan #RonnieScrewvala #VijayShekarSharma #KrisGopalakrishnan #BhavishAggarwal #RakutenMedical #funding #smitakumar #medicircle

Related Stories

Loading Please wait...


Trending Now

Empowering Consumers with Nutritional Information: FSSAI's New Labeling GuidelinesJuly 12, 2024
Innovative Migraine Research Uncovers Key Triggers and Pathways for PainJuly 12, 2024
Alarming Rise in Death's Due to HIV Among Students in Tripura: Urgent Need for ActionJuly 12, 2024
Amrita Vishwa Vidyapeetham is All Set to Produce Netravaad, an Innovative Technology for Speech Impairment July 11, 2024
Twice-Yearly Injection Shows 100% HIV Protection in Young WomenJuly 11, 2024
AIMS (Asian Hospital) Doctors Restore Disfigured Face of Road Accident VictimJuly 10, 2024
Will #PutPeopleFirst mantra drive HIV responses?July 10, 2024
Shiprocket and Snowflake AI Data Cloud to empower 1.5 lakh merchants of BHARAT to scale their data infrastructureJuly 10, 2024
Dr. Shilpa Vora, Marico expert shares tips on how you can safeguard your baby’s skin during the monsoon seasonJuly 10, 2024
Pre Budget 2024 (Ms. Deepshikha Sharma- CEO of Sharp Sight Eye Hospital) July 10, 2024
Rate of global warming caused by humans at an all-time high - research led by University of LeedsJuly 09, 2024
Dengue during Monsoon Season and Neurological Complications Associated with DengueJuly 09, 2024
Yodda Elder Care Renews Partnership with Medulance for Emergency ServicesJuly 09, 2024
Budget Expectation Quote- Dr. Sanjeev Singh, Medical Director, Amrita Hospital, FaridabadJuly 08, 2024
Honourable Justice R. Mahadevan, Chief Justice of Madras High Court, Chennai Inaugurates IIRSI 2024, India's Premier Convention on Eye SurgeryJuly 06, 2024
The Impact of Architecture on Academic Performance: How Exam Hall Design Affects Student SuccessJuly 06, 2024
Teen Dies from Brain-Eating Amoeba in Kerala: Fatal Naegleria fowleri Infections SurgeJuly 05, 2024
Chemotherapy Drug Linked to Long-Term Hearing Loss in Cancer SurvivorsJuly 05, 2024
Qatar Airways Chooses Çelebi India as Ground Handler for New Doha-Goa FlightsJuly 04, 2024
Zika Virus Alert in Maharashtra: Government's Proactive Steps for Public SafetyJuly 04, 2024